- Home
- About
- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- IgAN
- Events
- Resource Center
- Rare Kidney Diseases (PKD, IgAN, & Others)
- Kidney Disease & Mental Health
- Kidney Disease & Comorbid Conditions
- Transplantation & Dialysis
- NephU Nutrition & The NephChefR
- Radiology Toolkit
- On Demand Webinars
- Infographics
- Podcasts
- Videos
- Request a Presentation
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Archives
Diet Management In Autosomal Dominant Polycystic Kidney Disease (ADPKD): Ketogenic Diet – Part 1
In this Part 1 of a 3 Part series, we will briefly describe the pathophysiology of Autosomal Dominant Polycystic Kidney Disease (ADPKD) including its cellular, metabolic, and systemic impact. Then, we will discuss the nutritional/diet management strategies for ADPKD, with an emphasis on using the Ketogenic Diet. We will set the stage for Part 2, describing a Plant-Focused Ketogenic Diet Program for improved ADPKD outcomes.
*Dr Richard (Rick) Lindquist is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Laura Frank is an employee of OPDC.
Featured Speakers
Richard Lindquist, MD, FAASP, FOMA
Obesity Medicine Consultant-
Richard Lindquist Consulting, PLLC*
Dr Richard Lindquist is a board-certified Obesity Medicine and Family Medicine physician who graduated from the University of Washington and completed his residency at Bayfront Medical Center in Florida. Dr Lindquist is former Medical Program Director of Swedish Weight Loss Services in Seattle and former Medical Director for Providence St. Joseph Health System’s Health Weight Initiative. He is currently a consultant to hospitals and health care systems, assisting with weight management program planning, development, training, and education.
Dr Lindquist is actively involved in state and national organizations and has earned numerous awards and recognitions for his work, including the Obesity Medicine Association’s “Bariatrician of the Year” for his contributions in advancing the field of bariatric medicine. He is a Board member of the American Board of Obesity Medicine and is the WA State Representative of the Obesity Society and the Obesity Medicine Association for “Access to Care.” Current hot topic projects include Obesity in Renal disease, Ketosis in health and disease, and work on an upcoming book on The Ideal Bariatric Center: Developing and Maintaining the Modern Metabolic and Bariatric Program.
Laura Frank, PhD, MPH, RDN, CD
Nephrology Clinical & Scientific LiaisonLocation
Online
Related Events
-
Cooking Demo: Dietary Considerations for Patients with IgA Nephropathy
March 12, 2025 from 12:00 pm to 1:00 pm
Join Today for Instant Access to all NephU Offerings.
Membership is free!
Join NephU today at no cost to register for this event and access to other premium content.
- The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
- Quickly learn more about the topics that interest you.
- Access our library of on-demand kidney health resources
- Gain key insights from industry experts & though leaders.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.